RhumbLine Advisers’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.5M | Sell |
176,766
-16,969
| -9% | -$144K | ﹤0.01% | 2041 |
|
|
2025
Q1 | $1.56M | Buy |
193,735
+124
| +0.1% | +$997 | ﹤0.01% | 1944 |
|
|
2024
Q4 | $1.74M | Sell |
193,611
-180
| -0.1% | -$1.62K | ﹤0.01% | 1962 |
|
|
2024
Q3 | $1.42M | Sell |
193,791
-14,472
| -7% | -$106K | ﹤0.01% | 2084 |
|
|
2024
Q2 | $1.19M | Buy |
208,263
+24,371
| +13% | +$139K | ﹤0.01% | 2149 |
|
|
2024
Q1 | $921K | Buy |
183,892
+2,548
| +1% | +$12.8K | ﹤0.01% | 2297 |
|
|
2023
Q4 | $1.63M | Buy |
181,344
+664
| +0.4% | +$5.97K | ﹤0.01% | 2009 |
|
|
2023
Q3 | $1.4M | Buy |
180,680
+1,554
| +0.9% | +$12.1K | ﹤0.01% | 2027 |
|
|
2023
Q2 | $1.73M | Buy |
179,126
+5,624
| +3% | +$54.4K | ﹤0.01% | 1985 |
|
|
2023
Q1 | $1.9M | Buy |
173,502
+6,949
| +4% | +$76.2K | ﹤0.01% | 1831 |
|
|
2022
Q4 | $720K | Buy |
166,553
+2,672
| +2% | +$11.6K | ﹤0.01% | 2296 |
|
|
2022
Q3 | $1.23M | Buy |
163,881
+12,005
| +8% | +$90.2K | ﹤0.01% | 2028 |
|
|
2022
Q2 | $1.53M | Buy |
+151,876
| New | +$1.53M | ﹤0.01% | 1918 |
|